[Structure-effect relations in tertiary and quaternary pyrrolidine-carbinol esters and pyrrolidinol esters].
D000085:Acetates / Q000008:administration & dosage; D000143:Acids / Q000008:administration & dosage*; D000179:Acrylates / Q000008:administration & dosage; D000818:Animals; D002217:Carbachol / Q000008:administration & dosage* / Q000037:antagonists & inhibitors; D003864:Depression, Chemical; D004952:Esters / Q000008:administration & dosage; D005561:Formates / Q000008:administration & dosage; D006168:Guinea Pigs; D006325:Heart Atria / Q000187:drug effects; D007082:Ileum / Q000187:drug effects; D066298:In Vitro Techniques; D009539:Nicotinic Acids / Q000494:pharmacology; D011422:Propionates / Q000008:administration & dosage; D011759:Pyrrolidines / Q000008:administration & dosage*; D011955:Receptors, Drug / Q000187:drug effects*; D013268:Stimulation, Chemical
D000085:Acetates; D000143:Acids; D000179:Acrylates; D004952:Esters; D005561:Formates; D009539:Nicotinic Acids; D011422:Propionates; D011759:Pyrrolidines; D011955:Receptors, Drug; D002217:Carbachol
Struktur-Wirkungs-Beziehungen bei tertiären und quartären Pyrrolidine-carbinol-estern bzw. Pyrrolidinol-estern.